GLICLAGLAZE MET

Description

gliclazide and metformin hydrochloride tablets GLICLAGLAZE MET is a combination of two highly effective oral antidiabetic medicines: Gliclazide and Metformin Hydrochloride. It is specially formulated to help patients with type 2 diabetes mellitus control their blood sugar levels when diet and exercise alone are not sufficient. Gliclazide is a sulfonylurea that helps the pancreas release more insulin, thereby lowering blood sugar. Metformin Hydrochloride belongs to the biguanide class and works by reducing glucose production in the liver and improving insulin sensitivity, allowing better glucose uptake by the body’s cells. Together, these two active ingredients provide comprehensive blood sugar management for diabetic patients, lowering the risk of long-term complications such as heart disease, kidney damage, and nerve disorders. Uses of GLICLAGLAZE MET The primary use of GLICLAGLAZE MET is to manage and control type 2 diabetes mellitus. Its benefits include: Lowering high blood glucose levels. Improving insulin sensitivity in the body. Reducing the risk of diabetes-related complications such as retinopathy, nephropathy, and neuropathy. Supporting overall metabolic balance when combined with healthy lifestyle changes like diet and exercise. This medicine is typically recommended for adults whose blood sugar cannot be adequately controlled with metformin alone. Side Effects of GLICLAGLAZE MET Like all medicines, GLICLAGLAZE MET may cause some side effects, although not everyone experiences them. Common side effects include: Hypoglycemia (low blood sugar): dizziness, sweating, tremors, or hunger. Gastrointestinal issues: nausea, vomiting, diarrhea, abdominal discomfort. Headache or fatigue. Taste changes or metallic taste in the mouth. Rare but serious side effects include: Lactic acidosis (a rare but severe side effect of metformin, with symptoms like extreme tiredness, muscle pain, difficulty breathing). Severe allergic reactions such as rash, itching, or swelling. If any serious side effects occur, medical attention should be sought immediately. Precautions Before Using Before starting GLICLAGLAZE MET, patients should take the following precautions: Inform your doctor if you have a history of kidney or liver problems. Avoid alcohol consumption as it increases the risk of hypoglycemia and lactic acidosis. Pregnant and breastfeeding women should only use this medicine under medical supervision. Inform your doctor if you have heart disease, adrenal or pituitary insufficiency. Regular blood sugar monitoring is essential during treatment. Do not skip meals, as this can increase the risk of low blood sugar. Drug Interactions GLICLAGLAZE MET may interact with other medications, altering its effectiveness or increasing side effects. Patients should inform their doctor if they are taking: Other antidiabetic drugs or insulin. Antihypertensive drugs (like beta-blockers or ACE inhibitors). Anticoagulants (blood thinners). Certain antifungal or antibiotic medicines. Corticosteroids or diuretics, which may raise blood sugar. Always consult your doctor before starting or stopping any other medication while on GLICLAGLAZE MET. Conclusion GLICLAGLAZE MET (Gliclazide and Metformin Hydrochloride Tablets) is a powerful combination therapy designed to effectively control blood sugar levels in patients with type 2 diabetes mellitus. By combining the insulin-stimulating effect of Gliclazide with the insulin-sensitizing and glucose-lowering effect of Metformin, it ensures comprehensive and balanced diabetes management.